Beijing Shijitan Hospital, Capital Medical University
Beijing Shijitan Hospital, Capital Medical University
Beijing, Beijing Municipality, China6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT03683186 | |
| A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants. | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, dermatitis, neurodermatitis, skin disorder | Not yet recruiting | Phase 1 | 2026-06-01 | NCT07619183 | |
| Evaluation Criteria, Diagnostic Criteria, Surgical Indications, and Establishment of Surgical Standards for "Cerebral Tinnitus Syndrome" Caused by Internal Jugular Vein Stenosis. | Assessment, Self; Diagnostic Self Evaluation; Jugular Vein Anomaly (Disorder); Nerosurgery | Recruiting | Not applicable | 2026-05-01 | NCT07560280 | |
| Phase I Study of XTL6001 Injection in Healthy and Obese Subjects | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, overnutrition | Recruiting | Phase 1 | 2025-10-03 | NCT07205432 | |
| Phase I Study of MT1011 Injection in Healthy Subjects | Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation | Recruiting | Phase 1 | 2025-07-03 | NCT07024160 | |
| Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System | cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not applicable | 2021-08-06 | NCT04995159 |